Medindia

X

Codexis Names Vice President, Intellectual Property

Tuesday, September 23, 2008 General News J E 4
Advertisement
REDWOOD CITY, Calif., Sept. 23 Codexis, Inc., today announced the appointment of Lynn Marcus-Wyner, Ph.D., as Vice President, Intellectual Property. She will be responsible for managing the company's intellectual property strategy, activities, and patent portfolio and will report to Douglas Sheehy, Vice President, General Counsel and Secretary.



Dr. Marcus-Wyner joins Codexis from Danisco A/S, where as Senior Director, Intellectual Assets US, she managed the United States patent department of the Genencor division. Previously, she was in private intellectual property law practice representing clients, including Genencor International, Inc., and Novartis Corporation, and held a legal patent management position at Sandoz Agro Inc. Dr. Marcus-Wyner was also a Patent Attorney at Zeneca Inc. (formerly ICI Americas Inc). Dr. Marcus-Wyner has a J.D. from the University of the Pacific, McGeorge School of Law and a Ph.D. in plant physiology from the University of California, Davis. Prior to law school, Dr. Marcus-Wyner was an Assistant Professor in the Plant and Soil Science Department at the University of Massachusetts, Amherst.



"Building and protecting our intellectual property portfolio is a key success factor for Codexis," Mr. Sheehy said. "Dr. Marcus-Wyner has broad experience counseling life science and bioindustrial companies on intellectual property law matters, and brings a proven track record in managing this important function in our industry," Mr. Sheehy said. "We are very pleased to add her to the Codexis legal team."



Codexis is a leading developer of proprietary biocatalysts that the company believes have the potential to revolutionize chemistry-based manufacturing processes across a variety of industries. The company has used its technology platform to enable biocatalyst-based commercial-scale drug manufacturing processes and delivered biocatalysts and drug products to some of the world's leading pharmaceutical companies. Codexis has a funded research collaboration in the biofuels market, and the company is pursuing funded collaborations in several other bioindustrial markets, including carbon management, water treatment and chemicals.



CONTACT: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144, or Justin Jackson, jjackson@burnsmc.com, Burns McClellan, 212-213-0006

SOURCE Codexis, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Major Adult Vaccine Clinical Trial for Pneumonia P...
S
Insmed and Premacure Cite Study Results Demonstrat...